Home

Return to top of page

Archived News

2007
2006
2005
2004
2003

2007

October 23, 2007

Ascenta Therapeutics Highlights Multiple Data Presentations at this week’s AACR-NCI-EORTC International Conference in San Francisco

Return to top of page

August 24, 2007

Ascenta Therapeutics Presents New Clinical Data on AT-101 for the Treatment of Hormone-Refractory Prostate Cancer

Return to top of page

June 6, 2007

FierceBiotech Names Ascenta Therapeutics as One of the “Fierce 15" Biotech Companies of 2007

Return to top of page

April 13, 2007

Ascenta Therapeutics Highlights Multiple Data Presentations at Upcoming AACR Annual Meeting

Return to top of page

April 9, 2007

Ascenta Therapeutics Raises $50 Million in Series C Financing

Return to top of page

February 23, 2007

Ascenta Therapeutics Presents New Clinical Data on AT-101 Monotherapy for the Treatment of Hormone-Refractory Prostate Cancer

Return to top of page